Role of endogenous 4-1BB in the development of systemic lupus erythematosus

Immunology

Volumn 122, Issue 3, 2007, Pages 394-400

  Vinay, Dass S ^a   Choi, Jae H ^a,b   Kim, Jung D ^a,b   Choi, Beom K ^b   Kwon, Byoung S ^a,b  

^a LSU EYE CENTER   (United States)

^b University of Ulsan   (South Korea)

Author keywords

4 1BB; Autoantibodies; B cells; Kidney; Lupus

Indexed keywords

AUTOANTIBODY; CD137 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CELL NUCLEUS ANTIGEN; IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GENE DELETION; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY INJURY; LYMPHADENOPATHY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; MALE; MORTALITY; MOUSE; NEPHRITIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN DEFECT; SPLENOMEGALY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD137; AUTOANTIBODIES; B-LYMPHOCYTES; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHATIC DISEASES; MALE; MICE; MICE, INBRED MRL LPR; SKIN DISEASES; SPLEEN; SPLENOMEGALY; SURVIVAL ANALYSIS;

EID: 35048866361     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02653.x     Document Type: Article

References (28)

1. Fairhurst AM, Wandstrat AE, Wakeland EK. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 2006 92 : 1 69.
2. Jacobi AM, Diamond B. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J Exp Med 2005 202 : 341 4.
3. + T cell population bearing a distinctive β chain in MRL lpr/lpr mice suggests a role for the Fas protein in peripheral T cell selection. Eur J Immunol 1994 24 : 2761 6.
4. Musette P, Galelli A, Chabre H, Callard P, Peumans W, Truffa-Bachi P, Kourilsky P, Gachelin G. Urtica dioica agglutinin, a Vβ8.3-specific superantigen, prevents the development of the systemic lupus erythematosus-like pathology of MRL lpr/lpr mice. Eur J Immunol 1996 26 : 1707 11.
5. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity. Nat Rev Immunol 2003 3 : 609 20.
6. Vinay DS, Kwon BS. Dual immunoregulatory pathways of 4-1BB signaling. J Mol Med 2006 84 : 726 36.
7. Chen L. CD137 Pathway: Immunology and Diseases, 1st edn. New York, NY : Springer, 2006.
8. Vinay DS, Choi BK, Bae JS, Kim WY, Gebhardt BM, Kwon BS. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J Immunol 2004 173 : 4218 29.
9. Kwon BS, Hurtado JC, Lee ZH et al. Immune responses in 4-1BB (CD137)-deficient mice. J Immunol 2002 168 : 5483 90.
10. Lee SW, Vella AT, Kwon BS, Croft M. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J Immunol 2005 174 : 6803 8.
11. Maerten P, Kwon BS, Shen C et al. Involvement of 4-1BB (CD137)-4-1BB ligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis. Clin Exp Immunol 2006 143 : 228 36.
12. Sun Y, Chen HM, Subudhi SK, Chen L, Koka R, Chen L, Fu YX. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nature Med 2003 8 : 1405 13.
13. Foell J, Strahotin S, O'Neil SP et al. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB × NZW F1 mice. J Clin Invest 2003 111 : 1505 18.
14. Furukawa F, Tanaka H, Sekita K, Nakamura T, Horiguchi Y, Hamashima Y. Dermatopathalogical studies on skin lesions of MRL mice. Arch Dermatol Res 1984 276 : 186 94.
15. lpr mice: an example of disease regulation at the organ level. J Immunol 2001 167 : 2985 90.
16. Theofilopoulos AN, Dixon FJ. Etiopathogenesis of murine SLE. Immunol Rev 1981 55 : 179 216.
17. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985 37 : 269 390.
18. Peng S, Madaio M, Hughes D, Crispe IN, Owen MJ, Wen L, Hayday AH, Craft J. Murine lupus in the absence of αβ T cells. J Immunol 1996 156 : 4041 9.
19. + cell to SCID mice lacking functional B cell. Autoimmunity 1999 29 : 103 10.
20. Busser BW, Adair BS, Erikson J, Laufer TM. Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance. J Clin Invest 1983 112 : 1361 71.
21. Rajagopalan S, Zordan T, Tsokos GC, Datta SK. Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8-T helper cell lines that express the gamma delta T-cell antigen receptor. Proc Natl Acad Sci USA 1990 87 : 7020 4.
22. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 1991 9 : 243 69.
23. Grammer AC, Donner T, Lipsky PE. Abnormalities in B cell activity and the immunoglobulin repertoire in human systemic lupus erythematosus. Mol Pathol Autoimmun Dis 2001 2 : 282 318.
24. Lipsky PE. Systemic lupus ertymatosus: an autoimmune disease of B cell hyperactivity. Nature Immunol 2001 2 : 764 6.
25. Reap EA, Sobel ES, Jennette JC, Cohen PL, Eisenberg RA. Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease. J Immunol 1993 151 : 7316 23.
26. Berland R, Wortis HH. Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 2002 20 : 253 300.
27. Ito T, Ishikawa S, Sato T et al. Defective B1 cell homing to the peritoneal cavity and preferential recruitment of B1 cells in the target organs in a murine model for systemic lupus erythematosus. J Immunol 2004 172 : 3628 34.
28. Murakami M, Yoshioka H, Shirai T, Tsubata T, Honjo T. Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int Immunol 1995 7 : 877 82.